29 results
6-K
EX-99.1
IMVIQ
IMV Inc.
10 Nov 22
Report of Foreign Private Issuer for the Month of November, 2022
4:09pm
component, $4 to the warrants and $149 to the loan commitment at inception.
Monthly pro rata principal repayments start after 24 months from loan
6-K
EX-99.1
IMVIQ
IMV Inc.
11 Aug 22
Report of Foreign Private Issuer for the Month of August, 2022
7:13am
with the venture loan were $377 of which, $224 has been allocated to the debt component, $4 to the warrants and $149 to the loan commitment at inception
6-K
EX-99.2
IMVIQ
IMV Inc.
3 Jun 22
Notice of Annual and Special Meeting of Shareholders
9:00am
and mature business judgment; the commitment to devote the necessary time and effort in order to conduct his or her duties effectively; and, where required
6-K
EX-99.1
IMVIQ
IMV Inc.
13 May 22
Report of Foreign Private Issuer for the Month of May, 2022
7:12am
for which these warrants are exercisable will increase by 113,636, this represents a loan commitment. If the predetermined milestone is reached … were $377 of which, $224 has been allocated to the debt component, $4 to the warrants and $149 to the loan commitment at inception.
Monthly pro rata
40-F
2021 FY
EX-99.2
IMVIQ
IMV Inc.
17 Mar 22
Annual report (Canada)
7:06am
an additional $10,000 and issue two additional warrants to purchase 113,636 shares to the lender, this represents a loan commitment. Transactions … associated with the venture loan were $377 of which, $224 has been allocated to the debt component, $4 to the warrants and $149 to the loan commitment
40-F
EX-99.1
z2xzmwi2 es
17 Mar 22
Annual report (Canada)
7:06am
6-K
EX-99.2
n6cay
27 Dec 21
Current report (foreign)
12:00am
6-K
EX-99.2
h3soyexh hciut
18 May 21
Report of Foreign Private Issuer for the Month of May 2021
12:00am
6-K
EX-99.3
n2b4ydij 4ry
14 May 21
Notice of Annual and Special Meeting of Shareholders
10:16am
6-K
EX-99.1
413o23h31on fjmv8ch
12 May 21
IMV Inc. Announces First Quarter 2021 Financial and Operational Results and Expansion of its Clinical Pipeline
9:10am
6-K
EX-99.1
ptvcx3hzxcdilxonp
17 Mar 21
IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results
9:34am
6-K
EX-99.2
610lfs5nhldp1d
12 Nov 20
Report of Foreign Private Issuer for the Month of November, 2020
7:08am
6-K
EX-99.2
pvpvzy
12 Aug 20
Management’s Responsibility for Financial Reporting
7:08am
6-K
EX-99.1
sa4fhx96q86 c1l
20 Jul 20
IMV Announces Appointment of Michael P. Bailey to Board of Directors
9:38am
6-K
EX-99.2
0gsbc5h
3 Jun 20
Notice of Annual Meeting of Shareholders
10:44am
6-K
EX-99.1
drcrhc1kxw66 b9
18 Mar 20
IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19
9:00am
6-K
EX-99.1
62kdurj
11 Apr 19
Report of Foreign Private Issuer for the Month of April, 2019
10:16am
6-K
EX-99.1
4596a ut0y
3 Apr 19
New Preclinical Research Presented at AACR 2019 Reveals Unique Anti-Cancer Mechanism of Action Underscoring IMV’s Immunotherapy Program
12:58pm
40-F
EX-99.2
iua8s0 kd
1 Apr 19
Annual report (Canada)
3:26pm
6-K
EX-99.1
u95e4y3kkg8d
21 Mar 19
Management’s Responsibility for Financial Reporting
5:05pm